Continuous precipitation of IgG from CHO cell culture supernatant in a tubular reactor.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Biotechnology Journal

• Publication date

  2015-08-01

• Fields of study

  Medicine, Chemistry, Engineering

• Identifiers
  DOI 10.1002/biot.201400608PMID 25781580
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Combined polyethylene glycol and CaCl2 precipitation for the capture and purification of recombinant antibodies

  2014cited by this paper
• Structural characterization of IgG1 mAb aggregates and particles generated under various stress conditions.

  2014cited by this paper
• Economics of recombinant antibody production processes at various scales: Industry-standard compared to continuous precipitation.

  2014cited by this paper
• Separation of recombinant antibodies from DNA using divalent cations

  2014cited by this paper
• Ethanol precipitation for purification of recombinant antibodies.

  2014influential reference
• Fast and scalable purification of a therapeutic full‐length antibody based on process crystallization

  2013cited by this paper
• Protein crystallization in stirred systems—scale‐up via the maximum local energy dissipation

  2013cited by this paper
• Isolation of monoclonal antibody from a Chinese hamster ovary supernatant. I: assessment of different separation concepts.

  2013cited by this paper
• Protein a chromatography at high titers

  2013cited by this paper
• Highly linear pH gradients for analyzing monoclonal antibody charge heterogeneity in the alkaline range.

  2013cited by this paper
• Feasibility study of semi‐selective protein precipitation with salt‐tolerant copolymers for industrial purification of therapeutic antibodies

  2013cited by this paper
• Integrated continuous production of recombinant therapeutic proteins

  2012cited by this paper
• Continuous aqueous two-phase extraction of human antibodies using a packed column.

  2012cited by this paper
• State‐of‐the‐art in downstream processing of monoclonal antibodies: Process trends in design and validation

  2012cited by this paper
• Monoclonal antibody capture and viral clearance by cation exchange chromatography

  2012cited by this paper
• Bioinspired and sustainable chitosan-based monoliths for antibody capture and release

  2012cited by this paper
• A new large‐scale manufacturing platform for complex biopharmaceuticals

  2012cited by this paper
• Improving affinity chromatography resin efficiency using semi-continuous chromatography.

  2012cited by this paper
• Periodic counter-current chromatography -- design and operational considerations for integrated and continuous purification of proteins.

  2012cited by this paper
• An innovative approach for the characterization of the isoforms of a monoclonal antibody product

  2011cited by this paper
• A single-use purification process for the production of a monoclonal antibody produced in a PER.C6 human cell line.

  2011cited by this paper
• Maximizing productivity of CHO cell‐based fed‐batch culture using chemically defined media conditions and typical manufacturing equipment

  2010cited by this paper
• Industrialization of mAb production technology: The bioprocessing industry at a crossroads

  2009cited by this paper
• Selective antibody precipitation using polyelectrolytes: A novel approach to the purification of monoclonal antibodies

  2009cited by this paper
• High-performance monolith affinity chromatography for fast quantitation of immunoglobulin G.

  2009cited by this paper
• Heterogeneity of monoclonal antibodies.

  2008cited by this paper
• Integrated process for the purification of antibodies combining aqueous two-phase extraction, hydrophobic interaction chromatography and size-exclusion chromatography.

  2008cited by this paper
• Optimisation of aqueous two-phase extraction of human antibodies.

  2007cited by this paper
• Cation exchange chromatography in antibody purification: pH screening for optimised binding and HCP removal.

  2007cited by this paper
• Infrared spectroscopy of proteins.

  2007cited by this paper
• Comparison of protein A affinity sorbents III. Life time study.

  2006cited by this paper
• Factorial screening of antibody purification processes using three chromatography steps without protein A.

  2004cited by this paper
• Static Mixers in the Process Industries—A Review

  2003cited by this paper
• Identification of multiple sources of charge heterogeneity in a recombinant antibody.

  2001cited by this paper
• Concentration of viral vectors by co‐precipitation with calcium phosphate

  2001cited by this paper
• Electrophoresis In Practice

  1993cited by this paper
• Chapter 5 – Effects of engineering parameters on the precipitation, recovery and purification of proteins

  1993cited by this paper
• Processing of Solid–Liquid Suspensions

  1993cited by this paper
• Alcohol precipitation of proteins: The relationship of denaturation and precipitation for catalase

  1981cited by this paper
• Preparation and properties of serum and plasma proteins; a system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids.

  1946cited by this paper
• Preparation and properties of serum and plasma proteins; a system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids.

  1946cited by this paper

• High-throughput screening of mRNA precipitate filterability using automated image analysis

  2026cites this paper
• Continuous Precipitation of Biotherapeutics: A Review

  2026cites this paper
• Polyethylene glycol precipitation: fundamentals and recent advances

  2025influential citation
• Optimizing clarification processes in biopharmaceutical manufacturing through quality by design: Strategies, implications, and future prospects

  2025cites this paper
• Countercurrent preferential precipitation of acidic variants from monoclonal antibody pools

  2024cites this paper
• Development of a novel capture step for purification of antigen binding fragments (Fabs).

  2024cites this paper
• Modeling scalability of impurity precipitation in downstream biomanufacturing

  2024cites this paper
• Optimizing particle morphology during antibody precipitation for enhanced tangential flow filtration performance

  2024cites this paper
• Continuous precipitation of antibodies using oscillatory flow reactor: a proof of concept

  2023cites this paper
• Continuous cold ethanol precipitation of immunoglobulin G from human plasma

  2023cites this paper
• Development of continuous processing platform utilizing aqueous two-phase extraction for purification of monoclonal antibodies.

  2023cites this paper
• Preferential precipitation of acidic variants from monoclonal antibody pools

  2022cites this paper
• Mode and dosage time in polyethylene glycol precipitation process influences protein precipitate size and filterability

  2022cites this paper
• Methods for addressing host cell protein impurities in biopharmaceutical product development

  2022cites this paper
• Design of millidevices to expedite apparent solubility measurements

  2022cites this paper
• Control of Continuous Manufacturing Processes for Production of Monoclonal Antibodies

  2021cites this paper
• Structured bottom section in inclined settlers for efficient continuous solid-liquid separation and washing of the solid fraction

  2021cites this paper
• Process Analytical Technology for Precipitation Process Integration into Biologics Manufacturing towards Autonomous Operation—mAb Case Study

  2021cites this paper
• Continuous crystallization as a downstream processing step of pharmaceutical proteins: A review

  2020cites this paper
• Modeling the Residence Time Distribution of Integrated Continuous Bioprocesses.

  2020cites this paper
• Effects of precipitation process on the biophysical properties of highly concentrated proteins

  2020cites this paper
• Polyacrylic acid based plasma fractionation for the production of albumin and IgG: Compatibility with existing commercial downstream processes

  2020cites this paper
• Biotechnology and Bioengineering: Volume 117, Number 7, July 2020

  2020cites this paper
• Continuous downstream bioprocessing for intensified manufacture of biopharmaceuticals and antibodies

  2020cites this paper
• Continuous capture of recombinant antibodies by ZnCl2 precipitation without polyethylene glycol

  2020cites this paper
• One-step orientated immobilization of nanobodies and its application for immunoglobulin purification.

  2019cites this paper
• Precipitation as an Enabling Technology for the Intensification of Biopharmaceutical Manufacture.

  2019cites this paper
• Biotechnology and Bioengineering

  2019cites this paper
• Salt-enhanced permeabilization for monoclonal antibody precipitation and purification in a tubular reactor with a depth filtration membrane with advanced chromatin extraction

  2019cites this paper
• Continuous Manufacturing of Recombinant Therapeutic Proteins: Upstream and Downstream Technologies.

  2018cites this paper
• An integrated precipitation and ion-exchange chromatography process for antibody manufacturing: Process development strategy and continuous chromatography exploration.

  2018cites this paper
• Process integration and control in continuous bioprocessing

  2018cites this paper
• Flocculation of CHO cells for primary separation of recombinant glycoproteins: Effect on glycosylation profiles

  2018cites this paper
• Non-protein A purification platform for continuous processing of monoclonal antibody therapeutics.

  2018cites this paper
• Continuous Virus Inactivation: How to Generate a Plug Flow

  2018cites this paper
• Mechanisms of precipitate formation during the purification of an Fc‐fusion protein

  2018cites this paper
• New Bioprocessing Strategies: Development and Manufacturing of Recombinant Antibodies and Proteins

  2018cites this paper
• Tools Enabling Continuous and Integrated Upstream and Downstream Processes in the Manufacturing of Biologicals

  2017cites this paper
• Continuous Crystallization of Proteins in a Stirred Classified Product Removal Tank with a Tubular Reactor in Bypass

  2017cites this paper
• NEXT‐GENERATION CLARIFICATION TECHNOLOGIES FOR THE DOWNSTREAM PROCESSING OF ANTIBODIES

  2017cites this paper
• Continuous cell flocculation for recombinant antibody harvesting

  2017cites this paper
• Renaissance of protein crystallization and precipitation in biopharmaceuticals purification.

  2017cites this paper
• Continuous desalting of refolded protein solution improves capturing in ion exchange chromatography: A seamless process.

  2017cites this paper
• Integration of Upstream and Downstream in Continuous Biomanufacturing

  2017cites this paper
• Integrated Continuous Manufacturing of Biopharmaceuticals

  2017cites this paper
• Integrated continuous processing of proteins expressed as inclusion bodies: GCSF as a case study

  2017cites this paper
• Continuous Downstream Processing for Production of Biotech Therapeutics

  2017cites this paper
• Engineering Challenges of Continuous Biomanufacturing Processes (CBP)

  2017cites this paper
• DoE based integration approach of upstream and downstream processing regarding HCP and ATPE as harvest operation

  2016cites this paper
• Microheterogeneity of therapeutic monoclonal antibodies is governed by changes in the surface charge of the protein

  2016cites this paper
• Real-time monitoring of protein precipitation in a tubular reactor for continuous bioprocessing

  2016cites this paper
• Continuous polyethylene glycol precipitation of recombinant antibodies: Sequential precipitation and resolubilization

  2016cites this paper
• Continuous precipitation of process related impurities from clarified cell culture supernatant using a novel coiled flow inversion reactor (CFIR).

  2016cites this paper
• Clarification technologies for monoclonal antibody manufacturing processes: Current state and future perspectives

  2016cites this paper
• A new use for existing technology - continuous precipitation for purification of recombination proteins.

  2015cites this paper
• End-to-end integrated fully continuous production of recombinant monoclonal antibodies.

  2015cites this paper
• Editorial: Bioengineering for a better quality of life

  2015cites this paper